Onsite treatment of HCV infection with direct acting antivirals within an opioid treatment program

This publication has 21 references indexed in Scilit:

• A multidimensional education program at substance dependence treatment centers improves patient knowledge and hepatitis C care
  BMC Infectious Diseases, 2016
• Elbasvir–Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy
  Annals of Internal Medicine, 2016
• Global policy and access to new hepatitis C therapies for people who inject drugs
  International Journal of Drug Policy, 2015
• Recommendations for the management of hepatitis C virus infection among people who inject drugs
  International Journal of Drug Policy, 2015
• Ombitasvir/paritaprevir/r and dasabuvir plus ribavirin in HCV genotype 1-infected patients on methadone or buprenorphine
  Journal of Hepatology, 2015
• Epidemiology and natural history of HCV infection
  Nature Reviews Gastroenterology & Hepatology, 2013
• Breaking Down the Barriers to Hepatitis C Virus (HCV) Treatment Among Individuals With HCV/HIV Coinfection: Action Required at the System, Provider, and Patient Levels
  The Journal of Infectious Diseases, 2013
• Successful Integration of Hepatitis C Evaluation and Treatment Services With Methadone Maintenance
  Journal of Addiction Medicine, 2010
• Successful treatment of chronic hepatitis C with pegylated interferon in combination with ribavirin in a methadone maintenance treatment program
  Journal of Substance Abuse Treatment, 2009
• Intranasal Transmission of Hepatitis C Virus: Virological and Clinical Evidence
  Clinical Infectious Diseases, 2008